- Home
- IBM vs AZN Comparison
IBM vs AZN Comparison
Compare IBM & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBM
- AZN
- Stock Information
- Founded
- IBM 1911
- AZN 1992
- Country
- IBM United States
- AZN United Kingdom
- Employees
- IBM N/A
- AZN N/A
- Industry
- IBM Computer Manufacturing
- AZN Biotechnology: Pharmaceutical Preparations
- Sector
- IBM Technology
- AZN Health Care
- Exchange
- IBM Nasdaq
- AZN Nasdaq
- Market Cap
- IBM 219.5B
- AZN 205.5B
- IPO Year
- IBM N/A
- AZN 1993
- Fundamental
- Price
- IBM $249.20
- AZN $67.57
- Analyst Decision
- IBM Buy
- AZN Strong Buy
- Analyst Count
- IBM 14
- AZN 5
- Target Price
- IBM $254.21
- AZN $92.33
- AVG Volume (30 Days)
- IBM 4.8M
- AZN 5.2M
- Earning Date
- IBM 04-23-2025
- AZN 04-29-2025
- Dividend Yield
- IBM 2.70%
- AZN 2.28%
- EPS Growth
- IBM N/A
- AZN 22.71
- EPS
- IBM 5.83
- AZN 4.97
- Revenue
- IBM $62,832,000,000.00
- AZN $54,982,000,000.00
- Revenue This Year
- IBM $4.78
- AZN $9.27
- Revenue Next Year
- IBM $4.65
- AZN $6.02
- P/E Ratio
- IBM $42.78
- AZN $13.61
- Revenue Growth
- IBM 1.23
- AZN 15.48
- 52 Week Low
- IBM $163.53
- AZN $61.24
- 52 Week High
- IBM $266.45
- AZN $87.68
- Technical
- Relative Strength Index (RSI)
- IBM 55.54
- AZN 41.25
- Support Level
- IBM $234.34
- AZN $67.26
- Resistance Level
- IBM $256.52
- AZN $72.69
- Average True Range (ATR)
- IBM 5.39
- AZN 1.30
- MACD
- IBM 1.94
- AZN -0.03
- Stochastic Oscillator
- IBM 77.18
- AZN 12.03
About IBM International Business Machines Corporation
IBM looks to be a part of every aspect of an enterprise's IT needs. The company primarily sells software, IT services, consulting, and hardware. IBM operates in 175 countries and employs approximately 300,000 people. The company has a robust roster of business partners to service its clients, which include 95% of all Fortune 500 companies. Primary products include its mainframes, Red Hat software, transaction processing software, and IT consulting.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.